Chemical basis of combination therapy to combat antibiotic resistance
The antimicrobial resistance crisis is a global health issue requiring discovery and development of novel therapeutics. However, conventional screening of natural products or synthetic chemical libraries is uncertain. Combination therapy using approved antibiotics with inhibitors targeting innate r...
Saved in:
Main Authors: | , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/164619 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-164619 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-1646192023-02-11T23:33:45Z Chemical basis of combination therapy to combat antibiotic resistance Si, Zhangyong Pethe, Kevin Chan-Park, Mary B. School of Chemical and Biomedical Engineering Lee Kong Chian School of Medicine (LKCMedicine) Singapore Centre for Environmental Life Sciences and Engineering (SCELSE) Science::Chemistry::Biochemistry Antimicrobial Resistance Combination Therapy The antimicrobial resistance crisis is a global health issue requiring discovery and development of novel therapeutics. However, conventional screening of natural products or synthetic chemical libraries is uncertain. Combination therapy using approved antibiotics with inhibitors targeting innate resistance mechanisms provides an alternative strategy to develop potent therapeutics. This review discusses the chemical structures of effective β-lactamase inhibitors, outer membrane permeabilizers, and efflux pump inhibitors that act as adjuvant molecules of classical antibiotics. Rational design of the chemical structures of adjuvants will provide methods to impart or restore efficacy to classical antibiotics for inherently antibiotic-resistant bacteria. As many bacteria have multiple resistance pathways, adjuvant molecules simultaneously targeting multiple pathways are promising approaches to combat multi-drug-resistant bacterial infections. Ministry of Education (MOE) Submitted/Accepted version This work was funded and supported by the Singapore MOE Tier 3 grant (MOE2018-T3-1-003). 2023-02-07T05:23:54Z 2023-02-07T05:23:54Z 2023 Journal Article Si, Z., Pethe, K. & Chan-Park, M. B. (2023). Chemical basis of combination therapy to combat antibiotic resistance. JACS Au. https://dx.doi.org/10.1021/jacsau.2c00532 2691-3704 https://hdl.handle.net/10356/164619 10.1021/jacsau.2c00532 en MOE2018-T3-1-003 JACS Au © 2023 The Authors. All rights reserved. This paper was published by American Chemical Society in JACS Au and is made available with permission of The Authors. application/pdf |
institution |
Nanyang Technological University |
building |
NTU Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NTU Library |
collection |
DR-NTU |
language |
English |
topic |
Science::Chemistry::Biochemistry Antimicrobial Resistance Combination Therapy |
spellingShingle |
Science::Chemistry::Biochemistry Antimicrobial Resistance Combination Therapy Si, Zhangyong Pethe, Kevin Chan-Park, Mary B. Chemical basis of combination therapy to combat antibiotic resistance |
description |
The antimicrobial resistance crisis is a global health issue requiring discovery and development of novel therapeutics. However, conventional screening of natural products or synthetic chemical libraries is uncertain. Combination therapy using approved antibiotics with inhibitors targeting innate resistance mechanisms provides an alternative strategy to develop potent therapeutics. This review discusses the chemical structures of effective β-lactamase inhibitors, outer membrane permeabilizers, and efflux pump inhibitors that act as adjuvant molecules of classical antibiotics. Rational design of the chemical structures of adjuvants will provide methods to impart or restore efficacy to classical antibiotics for inherently antibiotic-resistant bacteria. As many bacteria have multiple resistance pathways, adjuvant molecules simultaneously targeting multiple pathways are promising approaches to combat multi-drug-resistant bacterial infections. |
author2 |
School of Chemical and Biomedical Engineering |
author_facet |
School of Chemical and Biomedical Engineering Si, Zhangyong Pethe, Kevin Chan-Park, Mary B. |
format |
Article |
author |
Si, Zhangyong Pethe, Kevin Chan-Park, Mary B. |
author_sort |
Si, Zhangyong |
title |
Chemical basis of combination therapy to combat antibiotic resistance |
title_short |
Chemical basis of combination therapy to combat antibiotic resistance |
title_full |
Chemical basis of combination therapy to combat antibiotic resistance |
title_fullStr |
Chemical basis of combination therapy to combat antibiotic resistance |
title_full_unstemmed |
Chemical basis of combination therapy to combat antibiotic resistance |
title_sort |
chemical basis of combination therapy to combat antibiotic resistance |
publishDate |
2023 |
url |
https://hdl.handle.net/10356/164619 |
_version_ |
1759058799718563840 |